Published in Tissue Antigens on August 01, 1999
Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol (2005) 2.14
The HLA class I A locus affects susceptibility to type 1 diabetes. Hum Immunol (2002) 1.98
Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am J Hum Genet (2002) 1.21
Enteropathy precedes type 1 diabetes in the BB rat. Gut (2004) 1.19
Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet (2002) 1.11
Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol (2001) 1.10
Genomewide linkage analysis of celiac disease in Finnish families. Am J Hum Genet (2001) 1.03
New aspects in celiac disease. World J Gastroenterol (2007) 0.97
Pancreatic endocrine and exocrine changes in celiac disease. World J Gastroenterol (2007) 0.96
MICA response to gliadin in intestinal mucosa from celiac patients. Immunogenetics (2004) 0.90
Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles. Immunogenetics (2003) 0.90
Prss16 is not required for T-cell development. Mol Cell Biol (2005) 0.84
Expanded dog leukocyte antigen (DLA) single nucleotide polymorphism (SNP) genotyping reveals spurious class II associations. Vet J (2011) 0.84
Analysis of the expression of MICA in small intestinal mucosa of patients with celiac disease. J Clin Immunol (2003) 0.82
Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4. BMC Genomics (2005) 0.79
Three microsatellites from the T1DGC MHC data set show highly significant association with type 1 diabetes, independent of the HLA-DRB1, -DQA1 and -DQB1 genes. Diabetes Obes Metab (2009) 0.76
Celiac-associated pancreatic disease. Ann Gastroenterol (2016) 0.75
Distribution of HLA class I alleles differs in celiac disease patients according to age of onset. Dig Dis Sci (2003) 0.75
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med (1998) 5.25
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med (1989) 4.30
Epidemic of coeliac disease in Swedish children. Acta Paediatr (2000) 3.94
Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet (1995) 3.87
The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med (2000) 3.73
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10
Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology (1989) 2.98
Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet (1995) 2.93
HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology (1993) 2.72
HLA-D restriction of the macrophage-dependent response of immune human T lymphocytes to PPD in vitro: inhibition by anti-HLA-DR antisera. Scand J Immunol (1978) 2.70
Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology (1998) 2.69
Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals. Nat Genet (1992) 2.63
HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Immunol (1980) 2.58
Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut (1995) 2.29
The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet (1999) 2.17
Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol (1980) 2.09
[Genetic diagnostic test for hemochromatosis]. Tidsskr Nor Laegeforen (1998) 2.02
Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci U S A (1998) 1.99
HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum (1980) 1.97
Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol (1987) 1.85
Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol (1998) 1.85
Macrophage-dependent response of immune human T lymphocytes to PPD in vitro. Influence of HLA-D histocompatibility. Scand J Immunol (1977) 1.84
Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6. Nature (1976) 1.82
Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med (2001) 1.78
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. Tissue Antigens (1986) 1.67
Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol (1981) 1.66
Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia (2008) 1.61
Lymphoepithelial interactions in the mucosal immune system. Gut (1988) 1.58
HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens (2004) 1.56
The human secretory immune system shows striking heterogeneity with regard to involvement of J chain-positive IgD immunocytes. J Immunol (1979) 1.55
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol (1996) 1.53
HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol (1982) 1.53
Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun (2004) 1.53
Development of the choroid plexus. Microsc Res Tech (2001) 1.52
T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol (1994) 1.52
Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR. Immunol Rev (1982) 1.51
T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol (2001) 1.50
The human mixed lymphocyte-endothelium culture interaction. Transplantation (1975) 1.50
A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun (2008) 1.47
CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology (1998) 1.45
Tumor necrosis factor-alpha up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J Immunol (1988) 1.43
Antigen-presenting properties of human vascular endothelial cells. J Exp Med (1980) 1.43
Studies on nutrition in severely neurologically disabled children in an institution. Acta Paediatr (1996) 1.43
Strong association between the HLA-Dw3-related B cell alloantigen -DRw3 and coeliac disease. Scand J Gastroenterol (1978) 1.43
HLA-D region molecules restrict proliferative T cell responses to antigen. Immunol Rev (1982) 1.42
Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut (1995) 1.40
Genetic screening of Scandinavian families with febrile seizures and epilepsy or GEFS+. Acta Neurol Scand (2007) 1.39
The genetic polymorphism of the fourth component of human complement: methodological aspects and a presentation of linkage and association data relevant to its localization in the HLA region. J Exp Med (1977) 1.38
HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur J Immunol (1999) 1.38
Isolation of pure functionally active CD8+ T cells. Positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres. J Immunol Methods (1986) 1.38
T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol (1994) 1.37
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35
Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand J Immunol (1987) 1.33
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet (1997) 1.32
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32
Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group. Nat Genet (1997) 1.31
On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens (1993) 1.31
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Human transplantation antigens. Appendix: current methods in histocompatibility testing. Transplant Rev (1969) 1.27
The human major histocompatibility system. Transplant Rev (1974) 1.25
Immune response patterns in coeliac disease. Serum antibodies to dietary antigens measured by an enzyme linked immunosorbent assay (ELISA). Clin Exp Immunol (1984) 1.25
Direct immunomagnetic quantification of lymphocyte subsets in blood. Clin Exp Immunol (1988) 1.24
HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes (1997) 1.22
HL-A antigens and susceptibility to diseases. A study of patients with acute lymphoblastic leukaemia, Hodgkin's disease, and childhood asthma. Tissue Antigens (1971) 1.22
Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol (1996) 1.22
The association between rheumatoid arthritis and the HLA antigen DR4. Ann Rheum Dis (1983) 1.21
Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia (2006) 1.20
HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol (2010) 1.20
T lymphocytes in human gut epithelium preferentially express the alpha/beta antigen receptor and are often CD45/UCHL1-positive. Scand J Immunol (1989) 1.20